CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $6,669,998
- in 2 filings, $6.7M under 10b5-1 plans
Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −9,470 | 0 | ||
| 2025-02-27 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) | −4,530 | 5,470 | ||
| 2024-06-25 | BATE KENNETH Director | Grant or award | +714 | 1,912 | ||
| 2024-06-25 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +1,105 | 1,105 | ||
| 2024-04-02 | BATE KENNETH Director | Option exercise 10b5-1 | +11,212 | $105.08 | $1.2M | 12,410 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −1,217 | $243.28 | $296K | 11,193 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −7,048 | $244.27 | $1.7M | 4,145 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −2,080 | $244.97 | $510K | 2,065 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −567 | $246.20 | $140K | 1,498 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −100 | $246.88 | $25K | 1,398 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −193 | $248.49 | $48K | 1,205 |
| 2024-04-02 | BATE KENNETH Director | Sale 10b5-1 | −7 | $249.05 | $2K | 1,198 |
| 2024-04-02 | BATE KENNETH Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,212 | 0 | ||
| 2024-04-01 | BATE KENNETH Director | Option exercise 10b5-1 | +10,000 | $9.45 | $95K | 11,198 |
| 2024-04-01 | BATE KENNETH Director | Option exercise 10b5-1 | +10,000 | $100.45 | $1.0M | 21,198 |
| 2024-04-01 | BATE KENNETH Director | Option exercise 10b5-1 | +1,277 | $105.08 | $134K | 22,475 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −6,698 | $255.62 | $1.7M | 15,777 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −7,411 | $256.49 | $1.9M | 8,366 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −2,790 | $257.33 | $718K | 5,576 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −2,104 | $258.24 | $543K | 3,472 |
Page 3 of 4 · 78 trades